BROOKLYN IMMUNOTHERAPEUTICS

CUSIP: 114082100 Class: COM

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022
Shares 12,700 Value ($000) $3 Avg Close — Range —
Q2 2022
Shares 12,700 Value ($000) $7 Avg Close — Range —
Q1 2022
Shares 137,700 Value ($000) $282 Avg Close — Range —
Q2 2021
Shares 15,000 Value ($000) $270 Avg Close — Range —
Q1 2021
Shares 17,500 Value ($000) $65 Avg Close — Range —